{
  "id": "58c9a8fe02b8c6095300002a",
  "type": "factoid",
  "question": "What alternate indication has Vanoxerine been repositioned for?",
  "ideal_answer": "Vanoxerine's effects were strongly frequency-dependent and we repositioned it for treatment of atrial fibrillation and flutter. Vanoxerine has been in clinical trials for Parkinsonism, depression and cocaine addiction but lacked efficacy.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/21615815",
    "http://www.ncbi.nlm.nih.gov/pubmed/27108936",
    "http://www.ncbi.nlm.nih.gov/pubmed/19817928",
    "http://www.ncbi.nlm.nih.gov/pubmed/19817929",
    "http://www.ncbi.nlm.nih.gov/pubmed/25684233",
    "http://www.ncbi.nlm.nih.gov/pubmed/26616666"
  ],
  "snippets": [
    {
      "text": "Vanoxerine's effects were strongly frequency-dependent and we repositioned it for treatment of atrial fibrillation and flutter.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26616666",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Vanoxerine: cellular mechanism of a new antiarrhythmic.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19817928",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Therefore, we proposed that vanoxerine might be antiarrhythmic.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19817929",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Vanoxerine is a promising, new, investigational antiarrhythmic drug.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21615815",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Oral vanoxerine prevents reinduction of atrial tachyarrhythmias: preliminary results.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21615815",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Vanoxerine's effects were strongly frequency-dependent and we repositioned it for treatment of atrial fibrillation and flutter.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26616666",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Therefore, we proposed that vanoxerine might be antiarrhythmic.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19817929",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Vanoxerine has characteristics of a potentially effective and safe antiarrhythmic.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19817928",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "BACKGROUND: Vanoxerine is a promising, new, investigational antiarrhythmic drug.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21615815",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Oral vanoxerine prevents reinduction of atrial tachyarrhythmias: preliminary results.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21615815",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Vanoxerine, a new drug for terminating atrial fibrillation and flutter.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19817929",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Vanoxerine is an oral, 1,4-dialkylpiperazine derivative antiarrhythmic drug being evaluated for pharmacological cardioversion of atrial fibrillation (AF",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27108936",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Oral vanoxerine converted AF/AFL to SR at a high rate, was well tolerated, and caused no ventricular proarrhythmia.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25684233",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [
    "https://www.nlm.nih.gov/cgi/mesh/2017/MB_cgi?field=uid&exact=Find+Exact+Term&term=D056687",
    "http://www.biosemantics.org/jochem#http://www.biosemantics.org/jochem#:4001200",
    "http://www.biosemantics.org/jochem#4001200",
    "http://www.biosemantics.org/jochem#http://www.biosemantics.org/jochem#:4258722",
    "http://www.biosemantics.org/jochem#4151584",
    "http://www.biosemantics.org/jochem#4258722",
    "http://www.biosemantics.org/jochem#http://www.biosemantics.org/jochem#:4151584",
    "https://www.nlm.nih.gov/cgi/mesh/2017/MB_cgi?field=uid&exact=Find+Exact+Term&term=D001145"
  ],
  "exact_answer": "atrial fibrillation and flutter"
}